ICEC 0942 ( ICEC0942;CT7001 )

Catalog No. M12761 CAS No. 1805833-75-3

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Group Booking Get Quotation Bulk Inquiry Add to Cart

Product Name

ICEC 0942
Note

Research use only, not for human use.
Brief Description

ICEC 0942 (CT7001) is a potent, selective, orally active CDK7 inhibitor with IC50 of 41 nM, displays 15-fold selectivity over CDK2 (IC50=578 nM)
Description

ICEC 0942 (CT7001) is a potent, selective, orally active CDK7 inhibitor with IC50 of 41 nM, displays 15-fold selectivity over CDK2 (IC50=578 nM);displays 45-, 15-, 230- and 30-fold selectivity over CDK1, CDK2, CDK5 and CDK9; demonstrates sensitivity against a wide range of cancer types with GI50 values ranging between 0.2-0.3 uM; shows substantial anti-tumor effects in xenografts of both breast and colorectal cancers, also exhibits complete growth arrest of ER-positive tumor xenografts combined with tamoxifen.Solid Tumors Phase 1 Clinical
Synonyms

ICEC0942;CT7001
Pathway

Angiogenesis
Target

CDK
Recptor

CDK
Research Area

Cancer
Indication

Solid Tumors

CAS Number

1805833-75-3
Formula Weight

394.52
Molecular Formula

C22H30N6O
Purity

>98% (HPLC)
Solubility

——
SMILES

CC(C)C1=C2N=C(C=C(N2N=C1)NCC3=CC=CC=C3)NCC4CCNCC4O
Chemical Name

(3R,4R)-4-(((7-(benzylamino)-3-isopropylpyrazolo[1,5-a]pyrimidin-5-yl)amino)methyl)piperidin-3-ol

1. Hazel P, et al. ChemMedChem. 2017 Mar 7;12(5):372-380.
2.Patel H, et al. Mol Cancer Ther. 2018 Mar 15. pii: molcanther.0847.2016.

Calculator

molnova catalog